145 related articles for article (PubMed ID: 17699159)
1. The RAS-dependent ERF control of cell proliferation and differentiation is mediated by c-Myc repression.
Verykokakis M; Papadaki C; Vorgia E; Le Gallic L; Mavrothalassitis G
J Biol Chem; 2007 Oct; 282(41):30285-94. PubMed ID: 17699159
[TBL] [Abstract][Full Text] [Related]
2. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
Chou YT; Lin HH; Lien YC; Wang YH; Hong CF; Kao YR; Lin SC; Chang YC; Lin SY; Chen SJ; Chen HC; Yeh SD; Wu CW
Cancer Res; 2010 Nov; 70(21):8822-31. PubMed ID: 20978205
[TBL] [Abstract][Full Text] [Related]
3. Differential repression of c-myc and cdc2 gene expression by ERF and PE-1/METS.
Hester KD; Verhelle D; Escoubet-Lozach L; Luna R; Rose DW; Glass CK
Cell Cycle; 2007 Jul; 6(13):1594-604. PubMed ID: 17525531
[TBL] [Abstract][Full Text] [Related]
4. ERF: an ETS domain protein with strong transcriptional repressor activity, can suppress ets-associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation.
Sgouras DN; Athanasiou MA; Beal GJ; Fisher RJ; Blair DG; Mavrothalassitis GJ
EMBO J; 1995 Oct; 14(19):4781-93. PubMed ID: 7588608
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional repressor ERF is a Ras/mitogen-activated protein kinase target that regulates cellular proliferation.
Le Gallic L; Sgouras D; Beal G; Mavrothalassitis G
Mol Cell Biol; 1999 Jun; 19(6):4121-33. PubMed ID: 10330152
[TBL] [Abstract][Full Text] [Related]
6. ERF nuclear shuttling, a continuous monitor of Erk activity that links it to cell cycle progression.
Le Gallic L; Virgilio L; Cohen P; Biteau B; Mavrothalassitis G
Mol Cell Biol; 2004 Feb; 24(3):1206-18. PubMed ID: 14729966
[TBL] [Abstract][Full Text] [Related]
7. Myc antagonizes Ras-mediated growth arrest in leukemia cells through the inhibition of the Ras-ERK-p21Cip1 pathway.
Vaqué JP; Navascues J; Shiio Y; Laiho M; Ajenjo N; Mauleon I; Matallanas D; Crespo P; León J
J Biol Chem; 2005 Jan; 280(2):1112-22. PubMed ID: 15528212
[TBL] [Abstract][Full Text] [Related]
8. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
9. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
Marcotte R; Chen JM; Huard S; Wang E
J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
[TBL] [Abstract][Full Text] [Related]
10. Ras-Erk signaling induces phosphorylation of human TLE1 and downregulates its repressor function.
Zahavi T; Maimon A; Kushnir T; Lange R; Berger E; Kornspan D; Grossman R; Anzi S; Shaulian E; Karni R; Nechushtan H; Paroush Z
Oncogene; 2017 Jun; 36(26):3729-3739. PubMed ID: 28192406
[TBL] [Abstract][Full Text] [Related]
11. Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions.
Koskinen PJ; Ayer DE; Eisenman RN
Cell Growth Differ; 1995 Jun; 6(6):623-9. PubMed ID: 7669717
[TBL] [Abstract][Full Text] [Related]
12. Cell growth suppression by thanatos-associated protein 11(THAP11) is mediated by transcriptional downregulation of c-Myc.
Zhu CY; Li CY; Li Y; Zhan YQ; Li YH; Xu CW; Xu WX; Sun HB; Yang XM
Cell Death Differ; 2009 Mar; 16(3):395-405. PubMed ID: 19008924
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional repression of Mad-Max complex by human umbilical cord blood stem cells downregulates extracellular signal-regulated kinase in glioblastoma.
Velpula KK; Dasari VR; Tsung AJ; Dinh DH; Rao JS
Stem Cells Dev; 2012 Jul; 21(10):1779-93. PubMed ID: 21933022
[TBL] [Abstract][Full Text] [Related]
14. Identification of a c-Jun N-terminal kinase-2-dependent signal amplification cascade that regulates c-Myc levels in ras transformation.
Mathiasen DP; Egebjerg C; Andersen SH; Rafn B; Puustinen P; Khanna A; Daugaard M; Valo E; Tuomela S; Bøttzauw T; Nielsen CF; Willumsen BM; Hautaniemi S; Lahesmaa R; Westermarck J; Jäättelä M; Kallunki T
Oncogene; 2012 Jan; 31(3):390-401. PubMed ID: 21706057
[TBL] [Abstract][Full Text] [Related]
15. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
[TBL] [Abstract][Full Text] [Related]
16. Mad4 is regulated by a transcriptional repressor complex that contains Miz-1 and c-Myc.
Kime L; Wright SC
Biochem J; 2003 Feb; 370(Pt 1):291-8. PubMed ID: 12418961
[TBL] [Abstract][Full Text] [Related]
17. Semaphorin-7a reverses the ERF-induced inhibition of EMT in Ras-dependent mouse mammary epithelial cells.
Allegra M; Zaragkoulias A; Vorgia E; Ioannou M; Litos G; Beug H; Mavrothalassitis G
Mol Biol Cell; 2012 Oct; 23(19):3873-81. PubMed ID: 22875994
[TBL] [Abstract][Full Text] [Related]
18. Induction of endogenous telomerase (hTERT) by c-Myc in WI-38 fibroblasts transformed with specific genetic elements.
Casillas MA; Brotherton SL; Andrews LG; Ruppert JM; Tollefsbol TO
Gene; 2003 Oct; 316():57-65. PubMed ID: 14563552
[TBL] [Abstract][Full Text] [Related]
19. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites.
Hurlin PJ; Quéva C; Eisenman RN
Genes Dev; 1997 Jan; 11(1):44-58. PubMed ID: 9000049
[TBL] [Abstract][Full Text] [Related]
20. Mnt-Max to Myc-Max complex switching regulates cell cycle entry.
Walker W; Zhou ZQ; Ota S; Wynshaw-Boris A; Hurlin PJ
J Cell Biol; 2005 May; 169(3):405-13. PubMed ID: 15866886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
